Mutational analysis of oculocutaneous albinism: A compact review

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kamaraj, Balu ^a   Purohit, Rituraj ^a  

^a VIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; MELANIN; MONOPHENOL MONOOXYGENASE; NITISINONE; PARVOVIRUS VECTOR; TYROSINASE RELATED PROTEIN 1; CARRIER PROTEIN; MEMBRANE PROTEIN; OCA2 PROTEIN, HUMAN; OXIDOREDUCTASE; SLC45A2 PROTEIN, HUMAN; TUMOR ANTIGEN; TYRP1 PROTEIN, HUMAN;

ALBINISM; BIOACCUMULATION; CHEDIAK HIGASHI SYNDROME; CHROMOSOME 4Q; COMPUTER MODEL; GENE; GENE LOCUS; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CHROMOSOME; MELANOCYTE; MELANOGENESIS; MOLECULAR DYNAMICS; MONOPHENOL MONOOXYGENASE GENE; MUTATIONAL ANALYSIS; NONHUMAN; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; OCULOCUTANEOUS ALBINISM 2 GENE; PIEBALDISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLC24A5 GENE; TYROSINASE RELATED GENE 1; BIOSYNTHESIS; CLASSIFICATION; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PIGMENT EPITHELIUM; PROCEDURES;

ALBINISM, OCULOCUTANEOUS; ANTIGENS, NEOPLASM; DNA MUTATIONAL ANALYSIS; HUMANS; MELANINS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; OXIDOREDUCTASES; PIGMENT EPITHELIUM OF EYE;

EID: 84904806740     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/905472     Document Type: Review

References (87)

1. Garrod A. E., Inborn Errors of Metabolism 1923 London, UK Frowde and Hodder & Stoughton
2. Wildsoet C. F., Oswald P. J., Clark S., Albinism: its implications for refractive development. Investigative Ophthalmology & Visual Science 2000 41 1 1 7 2-s2.0-0033987468 (Pubitemid 30036538)
3. Kasmann-Kellner B., Hille K., Pfau B., Eye and general illnesses in the public school for the blind and usually handicapped students in Saarland development in the last 20 years. Opthamologe 1998 95 1 51 54
4. Li W., He M., Zhou H., Bourne J. W., Liang P., Mutational data integration in gene-oriented files of the Hermansky-Pudlak Syndrome database. Human Mutation 2006 27 5 402 407 (Pubitemid 43673325)
5. Wei A., Li W., Hermansky-Pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis. Pigment Cell and Melanoma Research 2013 26 2 176 192 10.1111/pcmr.12051 2-s2.0-84874345140
6. Suzuki T., Miyamura Y., Inagaki K., Tomita Y., Characterization of the human RAB38 and RAB7 genes: exclusion of new major pathological loci for Japanese OCA. Journal of Dermatological Science 2003 32 2 131 136 10.1016/S0923-1811(03)00071-9 2-s2.0-0037486877 (Pubitemid 36870759)
7. Hutton S. M., Spritz R. A., Comprehensive analysis of oculocutaneous albinism among non-hispanic caucasians shows that OCA1 Is the most prevalent OCA type. Journal of Investigative Dermatology 2008 128 10 2442 2450 10.1038/jid.2008.109 2-s2.0-51749112040
8. Grønskov K., Ek J., Sand A., Scheller R., Bygum A., Brixen K., Brondum-Nielsen K., Rosenberg T., Birth prevalence and mutation spectrum in Danish patients with autosomal recessive albinism. Investigative Ophthalmology & Visual Science 2009 50 3 1058 1064 10.1167/iovs.08-2639 2-s2.0-62649158351
9. Mondal M., Sengupta M., Samanta S., Sil A., Ray K., Molecular basis of albinism in India: Evaluation of seven potential candidate genes and some new findings. Gene 2012 511 2 470 474 10.1016/j.gene.2012.09.012 2-s2.0-84868212392
10. Grønskov K., Dooley C. M., Østergaard E., Kelsh R. N., Hansen L., Levesque M. P., Vilhelmsen K., Møllgård K., Stemple D. L., Rosenberg T., Mutations in C10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. The American Journal of Human Genetics 2013 92 3 415 421 10.1016/j.ajhg.2013.01.006 2-s2.0-84876407121
11. Wei A. H., Zang D. J., Zhang Z., Liu X., He X., Yang L., Wang Y., Zhou Z., Zhang M., Dai L., Yang X., Li W., Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic Oculocutaneous albinism. Journal of Investigative Dermatology 2013 133 7 1834 1840 10.1038/jid.2013.49 2-s2.0-84879418343
12. Kausar T., Bhatti M. A., Ali M., Shaikh R. S., Ahmed Z. M., OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24. Clinical Genetics 2013 84 1 91 93 10.1111/cge.12019 2-s2.0-84879797845
13. Gargiulo A., Testa F., Rossi S., di Iorio V., Fecarotta S., de Berardinis T., Iovine A., Magli A., Signorini S., Fazzi E., Galantuomo M. S., Fossarello M., Montefusco S., Ciccodicola A., Neri A., Macaluso C., Simonelli F., Surace E. M., Molecular and clinical characterization of albinism in a large cohort of Italian patients. Investigative Ophthalmology and Visual Science 2011 52 3 1281 1289 10.1167/iovs.10-6091 2-s2.0-79955937460
14. Rooryck C., Morice-Picard F., Elçioglu N. H., Lacombe D., Taieb A., Arveiler B., Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell & Melanoma Research 2008 21 5 583 587 10.1111/j.1755-148X.2008.00496.x 2-s2.0-52149113510
15. Okoro A. N., Albinism in Nigeria. A clinical and social study. British Journal of Dermatology 1975 92 5 485 492 2-s2.0-0016500926
16. Puri N., Durham-Pierre D., Aquaron R., Lund P. M., King R. A., Brilliant M. H., Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene. Human Genetics 1997 100 5-6 651 656 10.1007/s004390050568 2-s2.0-0031410634 (Pubitemid 28072371)
17. Durham-Pierre D., Gardner J. M., Nakatsu Y., King R. A., Francke U., Ching A., Aquaron R., Del Marmol V., Brilliant M. H., African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nature Genetics 1994 7 2 176 179 10.1038/ng0694-176 2-s2.0-0028232893 (Pubitemid 24174657)
18. Stevens G., van Beukering J., Jenkins T., Ramsay M., An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in Southern African Negroids. American Journal of Human Genetics 1995 56 3 586 591 2-s2.0-0028945964
19. Stevens G., Ramsay M., Jenkins T., Oculocutaneous albinism (OCA2) in sub-Saharan Africa: Distribution of the common 2.7-kb P gene deletion mutation. Human Genetics 1997 99 4 523 527 10.1007/s004390050400 2-s2.0-0030969388 (Pubitemid 27152104)
20. Inagaki K., Suzuki T., Shimizu H., Ishii N., Umezawa Y., Tada J., Kikuchi N., Takata M., Takamori K., Kishibe M., Tanaka M., Miyamura Y., Ito S., Tomita Y., Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. The American Journal of Human Genetics 2004 74 3 466 471 10.1086/382195 2-s2.0-12144290965 (Pubitemid 38325917)
21. Boissy R. E., Albinism. eMedicine. 2003, http://emedicine.medscape.com/ article/1068184-overview
22. Tomita Y., Takeda A., Okinaga S., Tagami H., Shibahara S., Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochemical and Biophysical Research Communications 1989 164 3 990 996 10.1016/0006-291X(89)91767-1 2-s2.0-0024433692 (Pubitemid 19283942)
23. Kwon B. S., Haq A. K., Pomerantz S. H., Halaban R., Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proceedings of the National Academy of Sciences of the United States of America 1987 84 21 7473 7477 10.1073/pnas.84.21.7473 2-s2.0-0013587129 (Pubitemid 18035714)
24. Cooksey C. J., Garratt P. J., Land E. J., Pavel S., Ramsden C. A., Riley P. A., Smit N. P. M., Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. The Journal of Biological Chemistry 1997 272 42 26226 26235 10.1074/jbc.272.42.26226 2-s2.0-0030722720 (Pubitemid 27458833)
25. HGMD, The Human Gene Mutation Database at the Institute Medical Genetics in Cardiff 2013. http://www.hgmd.org/
26. Rinchik E. M., Bultman S. J., Horsthemke B., Lee S.-., Strunk K. M., Spritz R. A., Avidano K. M., Jong M. T. C., Nicholls R. D., A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993 361 6407 72 76 10.1038/361072a0 2-s2.0-0027509280 (Pubitemid 23020776)
27. Lee S.-T., Nicholls R. D., Jong M. T. C., Fukai K., Spritz R. A., Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 1995 26 2 354 363 10.1016/0888-7543(95)80220-G 2-s2.0-0028942723
28. Ancans J., Flanagan N., Hoogduijn M. J., Thody A. J., P-locus is a target for the melanogenic effects of MC-1R signaling: a possible control point for facultative pigmentation. Annals of the New York Academy of Sciences 2003 994 373 377 10.1111/j.1749-6632.2003.tb03202.x 2-s2.0-0038050981 (Pubitemid 36793889)
29. Sturm R. A., Duffy D. L., Box N. F., The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Research 2003 16 3 266 272 10.1034/j.1600-0749.2003.00041.x (Pubitemid 36597067)
30. Jannot A., Meziani R., Bertrand G., Gérard B., Descamps V., Archimbaud A., Picard C., Ollivaud L., Basset-Seguin N., Kerob D., Lanternier G., Lebbe C., Saiag P., Crickx B., Clerget-Darpoux F., Grandchamp B., Soufir N., Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. European Journal of Human Genetics 2005 13 8 913 920 10.1038/sj.ejhg.5201415 2-s2.0-23644448602 (Pubitemid 41131738)
31. Grønskov K., Ek J., Brondum-Nielsen K., Oculocutaneous albinism. Orphanet Journal of Rare Diseases 2007 2 1, article 43 10.1186/1750-1172-2-43 2-s2.0-38349160512
32. Rosemblat S., Durham-Pierre D., Gardner J. M., Nakatsu Y., Brilliant M. H., Orlow S. J., Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12071 12075 10.1073/pnas.91.25.12071 2-s2.0-0027944079 (Pubitemid 24368606)
33. Rebbeck T. R., Kanetsky P. A., Walker A. H., Holmes R., Halpern A. C., Schuchter L. M., Elder D. E., Guerry D., P gene as an inherited biomarker of human eye color. Cancer Epidemiology Biomarkers and Prevention 2002 11 8 782 784 2-s2.0-0036325172 (Pubitemid 34851915)
34. Korner A., Pawelek J., Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982 217 4565 1163 1165 10.1126/science.6810464 2-s2.0-0019945365 (Pubitemid 12069041)
35. Manga P., Boissy R. E., Pifko-Hirst S., Zhou B.-K., Orlow S. J., Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2. Experimental Eye Research 2001 72 6 695 710 10.1006/exer.2001.1006 2-s2.0-0034776868 (Pubitemid 32977216)
36. Brilliant M. H., The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Research 2001 14 2 86 93 10.1034/j.1600-0749.2001.140203.x 2-s2.0-0035088810 (Pubitemid 32258345)
37. Murty V. V. V. S., Bouchard B., Mathew S., Vijayasaradhi S., Houghton A. N., Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics 1992 13 1 227 229 10.1016/0888-7543(92)90228-K 2-s2.0-0026534062
38. Shibahara S., Taguchi H., Muller R. M., Shibata K., Cohen T., Tomita Y., Tagami H., Structural organization of the pigment cell-specific gene located at the brown locus in mouse: its promoter activity and alternatively spliced transcripts. Journal of Biological Chemistry 1991 266 24 15895 15901 2-s2.0-0026048137 (Pubitemid 21907742)
39. Sturm R. A., O'Sullivan B. J., Box N. F., Smith A. G., Smit S. E., Puttick E. R. J., Parsons P. G., Dunn I. S., Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. Genomics 1995 29 1 24 34 10.1006/geno.1995.1211 2-s2.0-0029095104
40. Box N. F., Wyeth J. R., Mayne C. J., O'Gorman L. E., Martin N. G., Sturm R. A., Complete sequence and polymorphism study of the human TYRP1 gene encoding tyrosinase-related protein 1. Mammalian Genome 1998 9 1 50 53 10.1007/s003359900678 2-s2.0-0031944118 (Pubitemid 28158993)
41. Vijayasaradhi S., Doskoch P. M., Houghton A. N., Biosynthesis and intracellular movement of the melanosomal membrane glycoprotein gp75, the human b (Brown) locus product. Experimental Cell Research 1991 196 2 233 240 10.1016/0014-4827(91)90256-T 2-s2.0-0026051621 (Pubitemid 121006397)
42. Halaban R., Moellmann G., Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity. Proceedings of the National Academy of Sciences of the United States of America 1990 87 12 4809 4813 10.1073/pnas.87.12.4809 2-s2.0-0025321144 (Pubitemid 20204193)
43. Kobayashi T., Imokawa G., Bennett D. C., Hearing V. J., Tyrosinase stabilization by Tyrp1 (the brown locus protein). The Journal of Biological Chemistry 1999 273 48 31801 31805 10.1074/jbc.273.48.31801 2-s2.0-0033610797 (Pubitemid 29177114)
44. Hirobe T., Abe H., Genetic and epigenetic control of the proliferation and differentiation of mouse epidermal melanocytes in culture. Pigment Cell Research 1999 12 3 147 163 10.1111/j.1600-0749.1999.tb00508.x 2-s2.0-0033146457 (Pubitemid 129686276)
45. Johnson R., Jackson I. J., Light is a dominant mouse mutation resulting in premature cell death. Nature Genetics 1992 1 3 226 229 10.1038/ng0692-226 2-s2.0-0026879472
46. Fang D., Tsuji Y., Setaluri V., Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Research 2002 30 14 3096 3106 10.1093/nar/gkf424 2-s2.0-0037100610 (Pubitemid 34846174)
47. Sarangarajan R., Boissy R. E., Tyrp1 and oculocutaneous albinism type 3. Pigment Cell Research 2001 14 6 437 444 10.1034/j.1600-0749.2001.140603.x 2-s2.0-0035542883 (Pubitemid 34010070)
48. Boissy R. E., Sakai C., Zhao H., Kobayashi T., Hearing V. J., Human tyrosinase related protein-1 (TRP-1) does not function as a DHICA oxidase activity in contrast to murine TRP-1. Experimental Dermatology 1998 7 4 198 204 10.1111/j.1600-0625.1998.tb00324.x 2-s2.0-0031690595 (Pubitemid 28419411)
49. Zhao H., Zhao Y., Nordlund J. J., Boissy R. E., Human TRP-1 has tyrosine hydroxylase but no dopa oxidase activity. Pigment Cell Research 1994 7 3 131 140 10.1111/j.1600-0749.1994.tb00040.x 2-s2.0-0028452014
50. Urabe K., Aroca P., Hearing V. J., From gene to protein: determination of melanin synthesis. Pigment Cell Research 1993 6 4 186 192 10.1111/j.1600-0749. 1993.tb00601.x 2-s2.0-0027639444
51. Olivares C., Jiménez-Cervantes C., Lozano J. A., Solano F., García-Borrón J. C., The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase. Biochemical Journal 2001 354 1 131 139 10.1042/0264-6021:3540131 2-s2.0-0035865591 (Pubitemid 32183453)
52. Newton J. M., Cohen-Barak O., Hagiwara N., Gardner J. M., Davisson M. T., King R. A., Brilliant M. H., Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. American Journal of Human Genetics 2001 69 5 981 988 10.1086/324340 2-s2.0-0034753365 (Pubitemid 33015813)
53. Fukamachi S., Shimada A., Shima A., Mutations in the gene encoding B, a novel transporter protein, reduce melanin content in medaka. Nature Genetics 2001 28 4 381 385 10.1038/ng584 2-s2.0-0034928757 (Pubitemid 32702430)
54. Harada M., Li Y. F., El-Gamil M., Rosenberg S. A., Robbins P. F., Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A0201-restricted T cells. Cancer Research 2001 61 3 1089 1094 2-s2.0-0035110963 (Pubitemid 32174429)
55. Rundshagen U., Zühlke C., Opitz S., Schwinger E., Käsmann-Kellner B., Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4. Human Mutation 2004 23 2 106 110 10.1002/humu.10311 2-s2.0-1042299964 (Pubitemid 38200600)
56. Inagaki K., Suzuki T., Ito S., Suzuki N., Adachi K., Okuyama T., Nakata Y., Shimizu H., Matsuura H., Oono T., Iwamatsu H., Kono M., Tomita Y., Oculocutaneous albinism type 4: six novel mutations in the membrane-associated transporter protein gene and their phenotypes. Pigment Cell Research 2006 19 5 451 453 10.1111/j.1600-0749.2006.00332.x 2-s2.0-33748295553 (Pubitemid 44326407)
57. Suzuki T., Inagaki K., Fukai K., A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene. British Journal of Dermatology 2005 152 1 174 175 10.1111/j.1365-2133.2005.06403.x 2-s2.0-13244281771
58. Costin G. E., Valencia J. C., Vieira W. D., Lamoreux M. L., Hearing V. J., Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. Journal of Cell Science 2003 116 15 3203 3212 10.1242/jcs.00598 2-s2.0-0041885144 (Pubitemid 37038968)
59. Cullinane A. R., Vilboux T., O'Brien K., Curry J. A., Maynard D. M., Carlson-Donohoe H., Ciccone C., Markello T. C., Gunay-Aygun M., Huizing M., Gahl W. A., Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia. Journal of Investigative Dermatology 2011 131 10 2017 2025 10.1038/jid.2011.157 2-s2.0-80052840923
60. Fanny M. P., Eulalie L., Stéphane F., SLC24A5 mutations are associated with non-syndromic oculocutaneous albinism. Journal of Investigative Dermatology 2013 10.1038/jid.2013.360
61. Lamason R. L., Mohideen M. P. K., Mest J. R., Wong A. C., Norton H. L., Aros M. C., Jurynec M. J., Mao X., Humphreville V. R., Humbert J. E., Sinha S., Moore J. L., Jagadeeswaran P., Zhao W., Ning G., Makalowska I., McKeigue P. M., O'Donnell D., Kittles R., Parra E. J., Mangini N. J., Grunwald D. J., Shriver M. D., Canfield V. A., Cheng K. C., Genetics: SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 2005 310 5755 1782 1786 10.1126/science.1116238 2-s2.0-29144485743 (Pubitemid 41814374)
62. Bella J., Hindle K. L., McEwan P. A., Lovell S. C., The leucine-rich repeat structure. Cellular and Molecular Life Sciences 2008 65 15 2307 2333 10.1007/s00018-008-8019-0 2-s2.0-49249092223
63. Bassi M. T., Schiaffino M. V., Renieri A., De Nigris F., Galli L., Bruttini M., Gebbia M., Bergen A. A. B., Lewis R. A., Ballabio A., Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nature Genetics 1995 10 1 13 19 10.1038/ng0595-13 2-s2.0-0029059066
64. Oh J., Ho L., Ala-Mello S., Amato D., Armstrong L., Bellucci S., Carakushansky G., Ellis J. P., Fong C., Green J. S., Heon E., Legius E., Levin A. V., Nieuwenhuis H. K., Pinckers A., Tamura N., Whiteford M. L., Yamasaki H., Spritz R. A., Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. The American Journal of Human Genetics 1998 62 3 593 598 10.1086/301757 2-s2.0-17344369131 (Pubitemid 28164616)
65. Depinho R. A., Kaplan K. L., The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine 1985 64 3 192 202 2-s2.0-0021889048 (Pubitemid 15041541)
66. Santiago Borrero P. J., Rodríguez-Pérez Y., Renta J. Y., Izquierdo N. J., Del Fierro L., Mũoz D., Molina N. L., Ramírez S., Pagán-Mercado G., Ortíz I., Rivera-Caragol E., Spritz R. A., Cadilla C. L., Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. Journal of Investigative Dermatology 2006 126 1 85 90 10.1038/sj.jid.5700034 2-s2.0-33644764019 (Pubitemid 43336098)
67. Witkop C. J., Rao G. H., Gaudier F., Nuñez Babcock M., Summers C. G., Shanahan F., Harmon K. R., Townsend D., Sedano H. O., King R. A., Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Boletin de la Asociacion Medica de Puerto Rico 1990 82 8 333 339 2-s2.0-0025473671
68. Jorizzo J., Bolognia J., Dermatology 2-Volume Set 2007 St. Louis, Mo, USA Mosby
69. Chediak M. M., New leukocyte anomaly of constitutional and familial character. Revue d'Hématologie 1952 7 3, article 362
70. Fukai K., Ishii M., Kadoya A., Chanoki M., Hamada T., Chediak-Higashi syndrome: report of a case and review of the Japanese literature. The Journal of Dermatology 1993 20 4 231 237 2-s2.0-0027337549 (Pubitemid 23217589)
71. Montoliu L., Grønskov K., Wei A. H., Increasing the complexity: new genes and new types of albinism. Pigment Cell & Melanoma Research 2014 27 1 11 18 10.1111/pcmr.12167
72. Simeonov D. R., Wang X., Wang C., Sergeev Y., Dolinska M., Bower M., Fischer R., Winer D., Dubrovsky G., Balog J. Z., Huizing M., Hart R., Zein W. M., Gahl W. A., Brooks B. P., Adams D. R., DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Human Mutation 2013 34 6 827 835 10.1002/humu.22315 2-s2.0-84878135768
73. Balu K., Purohit R., Mutational analysis of TYR gene and its structural consequences in OCA1A. Gene 2013 513 1 184 195 10.1016/j.gene.2012.09.128 2-s2.0-84872379319
74. Kamaraj B., Purohit R., Computational screening of disease-associated mutations in oca2 gene. Cell Biochemistry and Biophysics 2014 68 1 97 109 10.1007/s12013-013-9697-2 2-s2.0-84879536333
75. Kamaraj B., Purohit R., In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3. BioMed Research International 2013 2013 13 697051 10.1155/2013/697051 2-s2.0-84880171829
76. Lopez V. M., Decatur C. L., Stamer W. D., Lynch R. M., McKay B. S., L-DOPA is an endogenous ligand for OA1. PLoS Biology 2008 6 9, article e236 10.1371/journal.pbio.0060236 2-s2.0-55749083384
77. Lavado A., Jeffery G., Tovar V., de la Villa P., Montoliu L., Ectopic expression of tyrosine hydroxylase in the pigmented epithelium rescues the retinal abnormalities and visual function common in albinos in the absence of melanin. Journal of Neurochemistry 2006 96 4 1201 1211 10.1111/j.1471-4159.2006. 03657.x 2-s2.0-33645097316
78. Murillo-Cuesta S., Contreras J., Zurita E., Cediel R., Cantero M., Varela-Nieto I., Montoliu L., Melanin precursors prevent premature age-related and noise-induced hearing loss in albino mice. Pigment Cell & Melanoma Research 2010 23 1 72 83 10.1111/j.1755-148X.2009.00646.x
79. Slominski A., Zmijewski M. A., Pawelek J., L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell and Melanoma Research 2012 25 1 14 27 10.1111/j.1755-148X.2011. 00898.x 2-s2.0-83955164260
80. Gargiulo A., Bonetti C., Montefusco S., Neglia S., Di Vicino U., Marrocco E., Corte M. D., Domenici L., Auricchio A., Surace E. M., AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type 1 (OCA1). Molecular Therapy 2009 17 8 1347 1354 10.1038/mt.2009.112 2-s2.0-68249112028
81. Surace E. M., Domenici L., Cortese K., Cotugno G., Di Vicino U., Venturi C., Cellerino A., Marigo V., Tacchetti C., Ballabio A., Auricchio A., Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. Molecular Therapy 2005 12 4 652 658 10.1016/j.ymthe.2005.06.001 2-s2.0-25144523096 (Pubitemid 41350146)
82. Onojafe I. F., Adams D. R., Simeonov D. R., Zhang J., Chan C., Bernardini I. M., Sergeev Y. V., Dolinska M. B., Alur R. P., Brilliant M. H., Gahl W. A., Brooks B. P., Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism. The Journal of Clinical Investigation 2011 121 10 3914 3923 10.1172/JCI59372 2-s2.0-80053406581
83. Fukai K., Kunimoto H., Nakajima K., In vitro analysis of read-through effect of aminoglycosides to tyrosinase R278X nonsense mutation in melan-c cells. 25 Proceedings of the 24th Annual Meeting of the Japanese Society for Pigment Cell Research (JSPCR '12) 2012 904 922 Pigment Cell Melanoma & Research
84. Sivamani R. K., Goodarzi H., Garcia M. S., Raychaudhuri S. P., Wehrli L. N., Ono Y., Maverakis E., Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clinical Reviews in Allergy and Immunology 2013 44 2 121 140 10.1007/s12016-012-8301-7 2-s2.0-84878623453
85. Fitzmaurice S. D., Sivamani R. K., Isseroff R. R., Antioxidant therapies for wound healing: a clinical guide to currently commercially available products. Skin Pharmacology and Physiology 2011 24 3 113 126 10.1159/000322643 2-s2.0-78651406006
86. Sivamani R. K., Ghiya M., Maibach H. I., Shedding light on sunscreens and their labels. Testing policies need to match actual use. The American Journal of Preventive Medicine 2010 38 6 679 681 10.1016/j.amepre.2010.02.009 2-s2.0-77952352335
87. Sivamani R. K., Crane L. A., Dellavalle R. P., The benefits and risks to ultraviolet (UV) tanning and it alternatives: the role of prudent sun exposure. Dermatologic Clinics 2009 27 2 149 154 10.1016/j.det.2008.11.008 2-s2.0-60849126406